What You Should Know:
– MEDITECH, a healthcare information technology company, is joining forces with the Biden administration’s ambitious Cancer Moonshot initiative to improve cancer care through data standardization and collaboration.
– Announced at the ONC…
Continue Reading
Carrum Health’s collaboration with Florida Cancer Specialists & Research Institute facilitates a paradigm shift in breast cancer care accessibility. This union grants non-metastatic breast cancer patients associated with Carrum Health-linked employers a substantial two-year…
Continue Reading
Carrum Health, a digital marketplace for employers to purchase bundled healthcare services, announced it has partnered with Florida Cancer Specialists & Research Institute to offer employers in Florida breast cancer care services.Carrum Health offers…
Continue Reading
What You Should Know:
– Intelligent Scopes Corp, a subsidiary of Claritas HealthTech Ltd., and Mayo Clinic have joined forces to develop cutting-edge artificial intelligence (AI) solutions for bladder cancer diagnosis and treatment.
– The goal…
Continue Reading
Indian AI drug discovery firm gets $1M to focus on rare diseasesPeptris Technologies from Bangalore, India has received $1 million in pre-seed funding in a round led by Speciale Invest.
In a statement, the AI-driven…
Greater use of digital solutions could relieve the enormous pressure on cancer services, improve outcomes and personalise care, says consultant oncologist Penny KechagioglouWith around 3 million people living with cancer in the UK –…
Continue Reading
AI revolutionizes healthcare through precise medical imaging, AI-assisted surgeries, accelerated research, drug development, and early disease detection. Remote patient care, fraud prevention, accurate cancer diagnosis, and gene editing are redefining healthcare standards. Collaboration between…
Continue Reading
Top News
England’s Health Services Safety Investigations Body says that IT problems are among the most pressing in hospitals, noting that some of the reports it has reviewed involved patient deaths.
It gives examples of…
Lunit’s acquisition of Volpara at AUD 1.15 per share marks a pivotal move in cancer diagnostics. The Scheme Implementation Agreement targets Volpara’s AI-enabled solutions, expanding Lunit’s global presence. Volpara’s 100 million mammogram images promise…
Continue Reading
What You Should Know:
– South Korean AI leader Lunit has announced its intention to acquire Volpara, a global pioneer in AI-powered cancer detection software, in a landmark deal worth AUD 292M (USD 193M)….
Continue Reading
